Amount Raised
$21 Million
Round Type
Post-IPO Equity
BerwynBiotechnologyHealthcareInvestors
Description
On November 5, 2026, Annovis Bio, Inc. completed a public offering generating gross proceeds of approximately $21 million. The offering included 19 million shares of common stock and accompanying warrants. In addition, a company director participated by purchasing 5 million shares and accompanying warrants for $5 million.
Quick answer
Annovis Bio raised $21 Million in a Post-IPO Equity round, dated November 5, 2026. Investors: Company Director and Canaccord Genuity LLC. Annovis Bio is based in Berwyn, Pennsylvania, United States.
- How much did Annovis Bio raise?
- Annovis Bio raised $21 Million in a Post-IPO Equity round on November 5, 2026.
- Who invested in Annovis Bio?
- Company Director and Canaccord Genuity LLC are named as investors in this round.
- What does Annovis Bio do?
- Annovis Bio is pioneering a novel approach to fighting chronic and acute neurodegeneration, offering new hope against the largest unmet need of our aging population - Alzheimer’s and Parkinson’s diseases.
- Where is Annovis Bio based and how big is it?
- Annovis Bio is based in Berwyn, Pennsylvania, United States. Fundz records about 10 employees.
- Who are the decision-makers at Annovis Bio?
- Fundz holds 1 contact at Annovis Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Annovis Bio that raised within 45 days of this round, from Fundz verified event records.
- Equinox raised $1B on November 2, 2026.
- Endovia Health Sciences, Inc. raised $135M (Post-IPO Equity) on October 27, 2026.
- Araceli Biosciences raised $4.5M (Seed) on October 20, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
- X4 Pharmaceuticals raised $150M (Debt Financing) on October 12, 2026.
Who to call at Annovis Bio, and when
A new round usually means Annovis Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Annovis Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Annovis Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Annovis Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Annovis Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Annovis Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.